Catherine Ohura

Catherine Ohura, MS, PMP, currently serves as a Board Member at Sugi Holdings and is a member of the Board of Overseers at Temple University Japan and the Board of Governors for the American Chamber of Commerce in Japan. Catherine has extensive experience in the pharmaceutical industry, having held leadership roles at Labcorp, including General Manager for Japan, where responsibilities included shaping business strategy and ensuring regulatory compliance. As CEO of the Global Health Innovative Technology Fund, Catherine worked on international partnerships to combat infectious diseases. Previous positions also include significant roles at Bristol-Myers Squibb in areas such as commercial operations, R&D, and project management, and at Kyowa Hakko Kirin Pharma. Catherine holds an MS in Regulatory Affairs/Quality Assurance, is pursuing a PhD in Project Management, and has a BS in Chemistry.